Vaccsys Inc. Receives $9,000,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f1509c7f-0512-4401-8c21-22b2a42afac7&Preview=1 -
Date
6/18/2008 -
Company Name
Vaccsys Inc. -
Mailing Address
1124 Columbia St Seattle, WA 98104 -
Company Description
The company is developing vaccines that “regulate immune responses by targeting dendritic cell biology with combinations of proprietary vectors and adjuvants.” -
Website
http://www.vaccsys.com -
Transaction Type
Venture Equity -
Transaction Amount
$9,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Alta Partners -
Venture Investor
The Column Group -
Venture Investor
Versant Ventures
